Highlights from the 6th Annual Chicago Supportive Oncology Conference

 

A CME-certified supplement to the Journal of Supportive Oncology.

This supplement is supported by educational grants from Pfizer, Eisai, Meda, Purdue and an educational donation provided by Amgen Oncology

 

It is jointly sponsored by Northwestern University Feinberg School of Medicine and Global Academy for Medical Education and provided by Meniscus Educational Institute

This continuing medical education (CME) supplement was developed from selected sessions presented during the Sixth Annual Chicago Supportive Oncology Conference which was held October 7-9, 2010.

Estimated time to complete activity: 1.0 hour

Release Date: May 2011

Expiration Date: May 31, 2012

 

Click here to download ( PDF - 241KB)

 

---

Intended Audience

This continuing education activity is designed for physicians, nurses, nurse practitioners, physician assistants, residents, and fellows who will gain important insights about practical management issues in the palliative and supportive care of patients with neoplastic diseases.

Overall Purpose

Significant advances in early detection and treatment have allowed people to live many years after a cancer diagnosis. As treatment regimens become more complex, diverse, and disease specific, so do their acute and late effects. Patients face both treatment and disease-related effects—physical and psychological. Even after treatment is over, cancer survivors may continue to face physical, emotional, social, spiritual, and financial challenges. This activity will provide participants with the latest information on supportive care issues. The goal is to enable health care professionals to deliver state-of-the-art medical care, improve patient outcomes, and enhance the quality of life of patients with cancer. This activity will help reduce the barriers that prevent the integration of therapies into practice and support adherence to current guidelines.

Learning Objectives

After participating in this activity the learner should be better able to:

• Discuss the integration of palliative care into cancer care.

 

• Describe the use of a cancer pain staging/classification system

 

• Explain a psychological impact of erectile dysfunction men experience after cancer treatment

 

• Recognize potential different biological mechanisms behind symptom burden in the setting of stem cell transplantation

 

• Discuss a potential role of ginseng in cancer-related fatigue management

 

• Describe findings of the  SOAPP study of symptom management in outpatient oncology

 

• Summarize studies that have been used in the assessment of cognitive effects of therapy in breast cancer.

 

• Describe research on the association between patient-reported cognitive function and other approaches for the assessment of cognitive function (eg. neuropsychological performance, neuroimaging).

 

• Summarize the use of automated voice response (AVR) system as an intervention strategy to assist patients to adhere to oral biologics

 

• Describe antiemetic treatment guidelines in improving the control of nausea and emesis

 

• Identify some strategies to reduce stress in providers

 

• Discuss the use of “wish statements” in communicating painful news to cancer patients.

Continuing Education

 

To access the learning assessment and evaluation form online, visit CSOC10JSO.cme360.net

 

Statement of Credit—Participants who successfully complete this activity (including scoring at least 70% on the learning assessment and completing and submitting the evaluation form online) will be issued a statement of credit via e-mail or US mail within 4 weeks.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Northwestern University’s Feinberg School of Medicine and Global Academy for Medical Education, LLC. The Northwestern University Feinberg School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University’s Feinberg School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nurses. This activity for 1.6 contact hours is provided by the Meniscus Educational Institute.

 

The Meniscus Educational Institute is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

 

Accreditation refers to recognition of educational activities only and does not imply approval or endorsement by the Meniscus Educational Institute or the American Nurses Credentialing Center’s Commission on Accreditation of any product mentioned.

 

Provider approved by the California Board of Registered Nursing, Provider No. 13164, for 1.6 contact hours.

 

Disclaimer

This activity has been designed to provide continuing education that is focused on specific objectives. In selecting educational activities clinicians should pay special attention to the relevance of those objectives and the application to their particular needs. The intent of all Meniscus Educational Institute educational opportunities is to provide learning that will improve patient care. Clinicians are encouraged to reflect on this activity and its applicability to their own patient population.

 

The opinions expressed in this activity are those of the faculty and reviewers and do not represent an endorsement by MEI or the companies providing educational grant support of any specific therapeutics or approaches to diagnosis or patient management.

Product Disclosure

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product or consult the latest edition of the Physicians’ Desk Reference.

 

There is no fee for participating in this activity.

 

Program Chairperson

 

Jamie H. Von Roenn, MD

Professor of Medicine

Robert H. Lurie Comprehensive Cancer Center

Northwestern University Feinberg School of Medicine

Editor, The Journal of Supportive Oncology

Chicago, IL

Program Co-Chairs

 

Michael J. Fisch, MD, MPH

 Director, General Medical Oncology Program

The University of Texas

M. D. Anderson Cancer Center

Associate Editor, The Journal of Supportive Oncology

Houston, TX

 

Barbara A. Murphy, MD

Associate Professor of Medicine

Vanderbilt-Ingram Cancer Center

Associate Editor, The Journal of Supportive Oncology

Nashville, TN

 

 

Debra Barton, PhD, RN, AOCN, FAAN

Associate Professor, Oncology

Mayo Clinic

Associate Editor, The Journal of Supportive Oncology

Rochester, MN

 

Financial Disclosures

All individuals in positions to control the content of this program (eg, planners, faculty, content reviewers) are expected to disclose all financial relationships with commercial interests that may have a direct bearing on the subject matter of this continuing education activity. Participants have the responsibility to assess the impact (if any) of the disclosed information on the educational value of the activity. All faculty have been offered a modest honorarium from the accredited provider for their participation in this activity.

Education Committee and Content Reviewers

 

Karen Abbas, RN, MS, AOCN, has nothing to disclose.

 

Judith M. Fanelli, BA, RN, CCRP, has nothing to disclose.

 

Virginia R. Martin, MSN, RN, AOCN, has nothing to disclose.

 

Linda Moriarty, RN, BSN, OCN, has nothing to disclose.

 

Genevieve Napier has nothing to disclose.

 

Katy Quinn has nothing to disclose.

 

Sylvia Reitman has nothing to disclose.

 

Shirley Jones has nothing to disclose.

 

Faculty

 

Tim Ahles, MD, has nothing to disclose.

 

Walter F. Baile, MD, has nothing to disclose.

 

Debra Barton, PhD, RN, AOCN, FAAN, has received study supplies from Ginseng Board of Wisconsin and Ortho-McNeil Janssen Pharmaceuticals, Inc.

Robin Fainsinger, MD, has nothing to disclose.

Michael J. Fisch, MD, MPH, has nothing to disclose.

 

Sergio Giralt, MD, receives honoraria from Celgene Corporation, Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Genzyme Corporation.

 

Barbara Given, PhD, RN, FAAN, has nothing to disclose.

 

Mark G. Kris, MD, has nothing to disclose.

 

Barbara Murphy, MD, has nothing to disclose.

 

Christian J. Nelson, PhD, has nothing to disclose.

 

Timothy E. Quill, MD, has nothing to disclose.

 

Charles von Gunten, MD, has nothing to disclose.

 

Jamie H. Von Roenn, MD, has nothing to disclose.

 

Lynne I. Wagner, PhD, has nothing to disclose.

 

Susan Birk, has nothing to disclose

 

This activity is developed from scientific information presented at Sixth Annual Chicago Supportive Oncology Conference a continuing medical education (CME) conference convened in Chicago, Illinois, October 7 – 9, 2010.

The authors acknowledge the editorial assistance of Global Academy for Medical Education, LLC, an Elsevier business, and Susan Birk, medical writer, in the development of this supplement.

 
This supplement was produced by Global Academy for Medical Education, LLC, an Elsevier business. Neither the editors of Journal of Supportive Oncology nor the Editorial Advisory Board, nor the reporting staff contributed to its content. The opinions expressed in this supplement are those of the faculty and do not necessarily reflect the views of the supporter or of the Publisher.

 

Copyright © 2011 by Elsevier Inc. and its Licensors. All rights reserved. No part of this publication may be reproduced or transmitted in any form, by any means, without prior written permission of the Publisher. Elsevier Inc. will not assume responsibility for damages, loss, or claims of any kind arising from or related to the information contained in this publication, including any claims related to the products, drugs, or services mentioned herein.

---